Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis

Biochemical and Biophysical Research Communications

Volumn 300, Issue 1, 2003, Pages 230-235

  Park, Woo Hyun ^a   Cho, Yeon Hee ^a   Jung, Chul Won ^a   Park, Joon Oh ^a   Kim, Kihyun ^a   Im, Young Hyuck ^a   Lee, Mark H ^a   Kang, Won Ki ^a   Park, Keunchil ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apoptosis; Arsenic trioxide; Caspase; CDK; CDKI; Cell cycle; Cyclin; Renal cell carcinoma

Indexed keywords

ARSENIC TRIOXIDE; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL LEVEL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; ARSENICALS; BCL-X PROTEIN; CARCINOMA, RENAL CELL; CASPASES; CDC2-CDC28 KINASES; CELL CYCLE; CELL DIVISION; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; KIDNEY NEOPLASMS; OXIDES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 0037225985     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02831-0     Document Type: Article

References (31)

1. S.L. Soignet, P. Maslak, Z.G. Wang, S. Jhanwar, E. Calleja, L.J. Dardashti, D. Corso, A. Deblasio, J. Gabrilove, D.A. Scheinberg, P.P. Pandolfi, R. Warrell, Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide, N. Engl. J. Med. 339 (1998) 1341-1348.
2. W. Shao, M. Fanelli, F.F. Ferrara, R. Riccioni, A. Rosenauer, K. Davison, W.W. Lamph, S. Waxman, P.G. Pelicci, F.L. Coco, G. Avvisati, U. Testa, C. Peschle, C.G. Passerini, C. Nervi, W.H. Miller, Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells, J. Natl. Cancer Inst. 90 (1998) 124-133.
3. 3 induces NB4 cell apoptosis with down-regulation of Bcl-2 expression and modulation of PML-RARα/PML proteins, Blood 88 (1996) 1052-1061.
4. W.H. Park, J.G. Seol, E.S. Kim, J.M. Hyun, C.W. Jung, C.C. Lee, B.K. Kim, Y.Y. Lee, Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis, Cancer Res. 60 (2000) 3065-3071.
5. W. Zhang, K. Ohnishi, K. Shigeno, S. Fugisawa, K. Naito, S. Nakamura, K. Takeshita, A. Takeshita, R. Ohno, The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms, Leukemia 12 (1998) 1383-1391.
6. Z.G. Wang, R. Rivi, L. Delva, A. König, D.A. Scheinberg, C.G. Passerini, J. Gabrilove, R.P. Larrell, P.P. Pandolfi, Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARα independent manner, Blood 92 (1998) 1497-1504.
7. W.H. Miller Jr., H.M. Schipper, J.S. Lee, J. Singer, S. Waxman, Mechanisms of action of arsenic trioxide, Cancer Res. 62 (2002) 3893-3903.
8. J.G. Seol, W.H. Park, E.S. Kim, C.W. Jung, J.M. Hyun, Y.Y. Lee, B.K. Kim, Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells, Int. J. Oncol. 18 (2001) 249-255.
9. J.G. Seol, W.H. Park, E.S. Kim, C.W. Jung, J.M. Hyun, B.K. Kim, Y.Y. Lee, Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1, Biochem. Biophys. Res. Commun. 265 (1999) 400-404.
10. E.T. Snow, Metal carcinogenesis: Mechanistic implications, Pharmacol. Ther. 53 (1992) 31-65.
11. C.J. Sherr, Cancer cell cycle, Science 274 (1996) 1672-1677.
12. M. Malumbres, M. Barbacid, To cycle or not to cycle: A critical decision in cancer, Nat. Rev. Cancer 1 (2001) 222-231.
13. P.D. Jeffrey, A.A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, N.P. Pavletich, Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex, Nature 376 (1995) 313-320.
14. B.D. Dynlacht, Regulation of transcription by proteins that control the cell cycle, Nature 389 (1997) 149-152.
15. C.J. Sherr, J.M. Roberts, Inhibitors of mammalian G1 cyclin-dependent kinases, Genes Dev. 9 (1995) 1149-1163.
16. M. Peter, I. Herskowitz, Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle, Cell 79 (1994) 181-184.
17. S.J. Elledge, J.W. Harper, Cdk inhibitors: On the threshold of checkpoints and development, Curr. Opin. Cell Biol. 6 (1994) 847-852.
18. J. Brugarolas, C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, G.J. Hannon, Radiation-induced cell cycle arrest compromised by p21 deficiency, Nature 377 (1995) 552-557.
19. D.E. Fisher, Apoptosis in cancer therapy: Crossing the threshold, Cell 78 (1994) 539-542.
20. K.C. Zimmermann, C. Bonzon, D.R. Green, The machinery of programmed cell death, Pharmacol. Ther. 92 (2001) 57-70.
21. J.C. Reed, Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies, Semin. Hematol. 34 (1997) 9-19.
22. G.M. Cohen, Caspases: The executioners of apoptosis, Biochem. J. 326 (1997) 1-16.
23. N.A. Thornberry, Y. Lazebnik, Caspases: Enemies within, Science 281 (1998) 1312-1316.
24. B.G. Campling, J. Pym, R.P. Galbraith, S.P.C. Cole, Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells, Leukemia Res. 12 (1988) 823-831.
25. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A. Ibrado, J. Cai, T.L. Peng, D.P. Jones, X. Wang, Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked, Science 275 (1997) 1129-1132.
26. Y.H. Ling, J.D. Jiang, J.F. Holland, R. Perez-Soler, Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines, Mol. Pharmacol. 62 (2002) 529-538.
27. Y. Akao, Y. Nakagawa, K. Akiyama, Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro, FEBS Lett. 455 (1999) 59-62.
28. X-J. Huang, P.H. Wiernik, R.S. Klein, R.E. Gallagher, Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases, Med. Oncol. (Basingstoke) 16 (1999) 58-64.
29. H. Maeda, S. Hori, H. Nishitoh, H. Ichijo, O. Ogawa, Y. Kakehi, A. Kakizuka, Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer, Cancer Res. 61 (2001) 5432-5440.
30. 2+-dependent production of superoxide, Int. J. Cancer 92 (2001) 518-526.
31. A. Barchowsky, R.R. Roussel, L.R. Klei, P.E. James, N. Ganju, K.R. Smith, E.J. Dudek, Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways, Toxicol. Appl. Pharmacol. 159 (1999) 65-75.